Allergy to Solution Components: Individuals allergic to any components of the treatment solution I.e
In recent research articles, new drugs such as GLP-1 (glucagon-like peptide-1 receptor agonists), SGLT2 (sodium-glucose cotransporter-2 inhibitors) and RAAS (renin-angiotensin-aldosterone system inhibitors) have been found to slow down the progression of DKD (110, 111)
No gums, no sugar alcohols, no artificial sweeteners
Darber hinaus untersttzt es die Herzgesundheit durch die Verringerung des Risikos von Herzerkrankungen und Schlaganfall
Giulivi C, Zhang YF, Omanska-Klusek A, Ross-Inta C, Wong S, Hertz-Picciotto I, et al